Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy

Bladder cancer is the 10th most diagnosed cancer, with almost 10 M cancer deaths last year worldwide. Currently, chemotherapy is widely used as adjuvant therapy after surgical transurethral resection. Paclitaxel (PTX) is one of the most promising drugs, but cancer cells acquire resistance, causing f...

Descripción completa

Detalles Bibliográficos
Autores principales: Arista-Romero, Maria, Cascante, Anna, Fornaguera, Cristina, Borrós, Salvador
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618611/
https://www.ncbi.nlm.nih.gov/pubmed/34834374
http://dx.doi.org/10.3390/pharmaceutics13111959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618611/
https://www.ncbi.nlm.nih.gov/pubmed/34834374
http://dx.doi.org/10.3390/pharmaceutics13111959

Ejemplares similares